Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Biochemistry · China · 2025-02-27

Processing Time
292 days
Decision Date
2025-02-27
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins. Her work focuses on improving clinical outcomes in oncology, immunology, and anti-infection applications by creating tools to overcome therapeutic resistance and metastasis. Additionally, she aims to enhance production efficiency to ensure broader accessibility of life-saving treatments.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor was found to have national significance due to its potential to advance clinical care and strengthen U.S. biomedical competitiveness.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, patent activity, and federal funding support from NIH and NSF demonstrated her ability to advance the field.

3 Balance of Interests Met

USCIS determined that the petitioner's unique skillset and the benefits of her research to public health justified waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 4 peer-reviewed journal articles, 2 first-authored conference abstracts, and 1 first-authored book chapter. Her work garnered 127 citations and included an international patent application publication. Furthermore, her research was supported by funding from the National Science Foundation (NSF) and the National Institutes of Health (NIH).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Conference Presentations

Similar Cases

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
California 30 days 2023-02-09
The petitioner proposes to continue her research on advancing novel protein characterization approaches for discovering and engineering antibodies. This work focuses on developing a protein engineering strategy to produce antibodies with improved dose potency and creating new therapeutics that target difficult diseases.
View Case

Postdoctoral Researcher

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
California 489 days 2025-04-22
The petitioner proposes to develop synthetic antibodies with enhanced functional activity against infectious agents, specifically focusing on antibody engineering strategies for conditions like HIV. This work aims to create potent, long-acting solutions for disease prevention and treatment to lower transmission rates and healthcare burdens.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-27.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 292 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist